NCT07188298

Brief Summary

Risk Factors, and Clinical Outcomes of Neonatal Anemia in the NICU of a Tertiary Care Hospital

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
6mo left

Started Oct 2025

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Oct 2025Nov 2026

First Submitted

Initial submission to the registry

September 15, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 23, 2025

Completed
1 month until next milestone

Study Start

First participant enrolled

October 25, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 25, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

September 23, 2025

Status Verified

September 1, 2025

Enrollment Period

10 months

First QC Date

September 15, 2025

Last Update Submit

September 20, 2025

Conditions

Hemolytic Disease of NewbornAnemia of NeonatesSepsis

Outcome Measures

Primary Outcomes (1)

  • Understanding the local prevalence, associated factors, and outcomes of neonatal anemia

    To determine the prevalence of neonatal anemia among neonates admitted to a tertiary care neonatal intensive care unit (NICU * To identify maternal, perinatal, and neonatal risk factors associated with neonatal anemia * To assess short-term outcomes, including length of hospital stay, need for blood transfusion, morbidity, and mortality

    1 year

Eligibility Criteria

Age1 Day - 30 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

neonates

You may qualify if:

  • All live-born neonates admitted to the NICU within the first 24 hours of life.
  • Both term and preterm infants.

You may not qualify if:

  • Major congenital malformations
  • Chromosomal abnormalities or genetic syndromes
  • Neonates with a previous blood transfusion before study enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Erythroblastosis, FetalSepsis

Condition Hierarchy (Ancestors)

Fetal DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesHematologic DiseasesHemic and Lymphatic DiseasesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesImmune System DiseasesInfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • safwat abdelaziz

    Assiut University

    STUDY DIRECTOR

  • m hamdy ghazaly

    Assiut University

    STUDY DIRECTOR

Central Study Contacts

Ali Harris

CONTACT

+201061020985saleh111.osman@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Lecturer

Study Record Dates

First Submitted

September 15, 2025

First Posted

September 23, 2025

Study Start

October 25, 2025

Primary Completion (Estimated)

August 25, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

September 23, 2025

Record last verified: 2025-09